Patients' Expectations about Effects of Chemotherapy for Advanced Cancer

Jane C. Weeks(King Edward Memorial Hospital), Deborah Schrag(Dana-Farber Brigham Cancer Center), Paul J. Catalano(Computational Physics (United States)), Jennifer W. Mack(Dana-Farber Cancer Institute), Angel M. Cronin, Matthew Finkelman(Tufts University), Nancy L. Keating(Brigham and Women's Hospital)
New England Journal of Medicine
October 24, 2012
10.1056/nejmoa1204410
Cited by 1,150

Related Papers

How To Build and Interpret a Nomogram for Cancer Prognosis
|Journal of Clinical Oncology|2008|3.4k
Symptom Monitoring With Patient-Reported Outcomes During Routine Cancer Treatment: A Randomized Controlled Trial
|Journal of Clinical Oncology|2015|2.6k
Diagnosis and Treatment of Metastatic Colorectal Cancer
|JAMA|2021|2.6k
Overall Survival Results of a Trial Assessing Patient-Reported Outcomes for Symptom Monitoring During Routine Cancer Treatment
|JAMA|2017|2.3k
Bevacizumab in Combination With Oxaliplatin, Fluorouracil, and Leucovorin (FOLFOX4) for Previously Treated Metastatic Colorectal Cancer: Results From the Eastern Cooperative Oncology Group Study E3200
|Journal of Clinical Oncology|2007|2.3k